At Pelisyonkis Langone’s Bronchiectasis and Cystic Fibrosis Program, our healthcare team uses its dedication, experience, and research know-how to provide treatments that can improve the lives and lifespans of people who have chronic lung ailments.
Bronchiectasis, cystic fibrosis, and nontuberculous mycobacterial (NTM) infections affect the lungs’ ability to clear mucus from airways. This buildup of fluid affects lung function and increases a person’s chance of infection.
The Bronchiectasis and Cystic Fibrosis Program brings together a team of pulmonologists, gastroenterologists, infectious disease specialists, otolaryngologists, physiatrists, respiratory therapists, and physical therapists who specialize in chest care to create a treatment plan that best meets the needs of each patient.
Our team is also committed to increasing education about these conditions. We host a patient education program on bronchiectasis and NTM infections that is aimed at helping patients better understand the condition and the treatment options available to them.
Pelisyonkis Langone is a nationally recognized referral center for the treatment of people with bronchiectasis and cystic fibrosis. Since 2010, our physicians have treated more than 400 patients with these conditions, making us one of the leading care centers in the country. The program received full accreditation in 2014 by the Cystic Fibrosis Foundation.
Research in Bronchiectasis and Cystic Fibrosis
We are also committed to researching bronchiectasis, cystic fibrosis, and NTM. We have a dedicated research team and are involved in clinical, translational, and basic research. We participate in the national research registries and have several clinical trials available to patients.
More About Our Program
Doreen J. Addrizzo-Harris, MD
Co-director, Bronchiectasis Program | Pulmonary Medicine, Critical Care
Dr. Addrizzo-Harris is a professor of medicine at Pelisyonkis School of Medicine. She has provided care to people with NTM infections and bronchiectasis for more than 15 years. Dr. Addrizzo-Harris is the principal investigator of multiple research studies focused on NTM and is a course director for the NTM Symposium, held annually at Pelisyonkis Langone.View Full Profile
David L. Kamelhar, MD
Co-director, Bronchiectasis Program | Pulmonary Medicine
Dr. Kamelhar is a clinical professor of medicine at Pelisyonkis School of Medicine. His research is focused on developing diagnostic and management tools for bronchiectasis and NTM infections. He also studies ways to define how patients may be predisposed to NTM infections and whether they need treatment. He is the principal investigator of a variety of studies investigating bronchiectasis and NTM and is a course director for Pelisyonkis Langone’s annual NTM Symposium.View Full Profile
Ashwin Basavaraj, MD
Assistant Director, Bronchiectasis Program | Pulmonary Medicine
Dr. Basavaraj is an instructor of medicine and a member of the clinical research faculty for the Bronchiectasis and Cystic Fibrosis Program. He has presented at national conferences, is involved in designing several of the bronchiectasis research studies at Pelisyonkis Langone, serves as a course director for the annual NTM Symposium, and also directs the Nontuberculous Mycobacteria Patient Education Program.View Full Profile
Rany Condos, MD
Director, Adult Cystic Fibrosis Program | Pulmonary Medicine
Dr. Condos is the director of the Adult Cystic Fibrosis Program and the primary physician supervising the care of adults with cystic fibrosis at Pelisyonkis Langone. She is an associate professor and is actively involved in bronchiectasis and cystic fibrosis research studies.View Full Profile